Narendra D. Lalwani

Executive Vice President, Research & Development at Esperion Therapeutics, Inc.

Narendra D. Lalwani

Narendra D. Lalwani

Executive Vice President, Research & Development at Esperion Therapeutics, Inc.

Overview
RelSci Relationships

130

Number of Boards

1

Birthday

1953

Age

66

Relationships
RelSci Relationships are individuals Narendra D. Lalwani likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Cerenis Therapeutics Holding SA

Relationship likelihood: Strong

Chief Executive Officer at EVOQ Therapeutics LLC

Relationship likelihood: Strong

Senior Vice President-Clinical Development & Operation at Cerenis Therapeutics Holding SA

Relationship likelihood: Strong

Senior Vice President at Esperion Therapeutics, Inc.

Relationship likelihood: Strong

Former Chief Scientific Officer & Senior Vice President at Warner-Lambert Co.

Relationship likelihood: Strong

Co-Founder at Esperion Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Esperion Therapeutics, Inc.

Relationship likelihood: Strong

Former Chemistry Director at Pfizer, Inc.

Relationship likelihood: Strong

Vice President, Preclinical Development at ONL Therapeutics, Inc.

Relationship likelihood: Average

Former Head of Research at Esperion Therapeutics, Inc.

Relationship likelihood: Average

Paths to Narendra D. Lalwani
Potential Connections via
Relationship Science
You
Narendra D. Lalwani
Executive Vice President, Research & Development at Esperion Therapeutics, Inc.
Education

The University of Mumbai (known earlier as University of Bombay) is one of the oldest and premier Universities in India. It was established in 1857 consequent upon "Wood's Education Dispatch", and it is one amongst the first three Universities in India.

Gujarat University is a University serving in India and offers a myriad of classes to graduates and undergraduates.

The Stephen M. Ross School of Business at the University of Michigan is a vibrant and distinctive learning community grounded in the principle that business can be an extraordinary vehicle for positive change in today's dynamic global economy. At the Ross School of Business, our mission is to develop leaders who make a positive difference in the world. Through thought and action, members of the Ross community drive change and innovation that improves business and society.

Career History
Executive Vice President, Research & Development
2014 - Current

Esperion Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). It offers Bempedoic acid and Ezetime combination pill as therapies that have been shown to lower elevated LDL-C levels in patients with hypercholesterolemia, including patients inadequately treated with current lipid-modifying therapies. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Chief Scientific Officer
2007 - 2014

Cerenis Therapeutics Holding SA is a biopharmaceutical company, which engages in development of high density lipoprotein therapies for the treatment of cardiovascular and metabolic diseases. Its therapies consist of CER 001 and 209. The company was founded by Jean-Louis Dasseux on March 24, 2005 and is headquartered in Labege, France.

Professional
Prior

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Boards & Committees
Director
Prior

Esperion Therapeutics, Inc. operates as a clinical stage pharmaceutical company, which engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). It offers Bempedoic acid and Ezetime combination pill as therapies that have been shown to lower elevated LDL-C levels in patients with hypercholesterolemia, including patients inadequately treated with current lipid-modifying therapies. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1 - $99
2006

The American Red Cross, Washtenaw-Lenawee Chapter serves the residents of Lenawee and Washtenaw Counties. The American Red Cross prevents and alleviates human suffering in the face of emergencies by mobilizing the power of volunteers and the generosity of donors. As one Red Cross family, we claimed these values which we hope to most exemplify in our daily activities together. Teamwork, Trust, Commitment, Diversity, Respect and Integrity. Our programs rely on financial support and voluntary service from generous citizens of Washtenaw and Lenawee Counties.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Narendra D. Lalwani. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Narendra D. Lalwani's profile does not indicate a business or promotional relationship of any kind between RelSci and Narendra D. Lalwani.